¾Æ¸£º¸¹ÙÀÌ·¯½º °Ë»ç ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2025-2032³â)
Arbovirus Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
ÁÖ¿ä Á¶»ç °á°ú
¾Æ¸£º¸¹ÙÀÌ·¯½º °Ë»ç ½ÃÀå ±Ô¸ð : 10¾ï 9,440¸¸ ´Þ·¯(2025³â)
¿¹»ó ½ÃÀå ±Ô¸ð : 15¾ï 2,110¸¸ ´Þ·¯(2032³â)
¼¼°è ½ÃÀå ¼ºÀå·ü : 4.8%(2025-2032³â CAGR)
¾Æ¸£º¸¹ÙÀÌ·¯½º °Ë»ç ½ÃÀå : º¸°í¼ ¹üÀ§
¾Æ¸£º¸¹ÙÀÌ·¯½º °Ë»ç´Â µ±â¿, ÁöÄ«¹ÙÀÌ·¯½º, Ä¡Äﱸ´Ï¾ß¿, Ȳ¿, ¿þ½ºÆ®³ªÀϹÙÀÌ·¯½º µî ÀýÁöµ¿¹° ¸Å°³ ¹ÙÀÌ·¯½º °¨¿°ÁõÀÇ Áø´Ü°ú °¨½Ã¿¡¼ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. À̵é Áúº´Àº ÁÖ·Î ¸ð±â¿Í Áøµå±â¿¡ ÀÇÇØ ¸Å°³µÇ¸ç, ƯÈ÷ ¿´ë ¹× ¾Æ¿´ë Áö¿ª¿¡¼ °øÁߺ¸°Ç¿¡ ½É°¢ÇÑ ¹®Á¦°¡ µÇ°í ÀÖ½À´Ï´Ù. ¾Æ¸£º¸¹ÙÀÌ·¯½º °Ë»ç ½ÃÀåÀº ºÐÀÚÁø´Ü, Ç÷ûÇÐÀû °Ë»ç, ÇöÀå °Ë»ç, º´¿ø, Áø·á¼Ò, ½ÇÇè½Ç, ÇöÀå °¨½Ã ÇÁ·Î±×·¥¿¡¼ »ç¿ëµÇ´Â ÇöÀå °Ë»ç·Î ±¸¼ºµË´Ï´Ù. ¾Æ¸£º¸¹ÙÀÌ·¯½º °¨¿°ÁõÀÇ À¯Çà°ú ´õºÒ¾î Àü ¼¼°èÀûÀÎ À̵¿ÀÇ Áõ°¡¿Í ±âÈĺ¯È°¡ ¸Å°³µ¿¹° »ýŰ迡 ¹ÌÄ¡´Â ¿µÇâÀº ÷´Ü Áø´Ü ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù.
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
¼¼°è ¾Æ¸£º¸¹ÙÀÌ·¯½º °Ë»ç ½ÃÀåÀº µµ½ÃÈ, ¼¼°è ¿©Çà, ¸ð±â ¹ø½Ä¿¡ À¯¸®ÇÑ È¯°æ º¯È µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ Àü ¼¼°èÀûÀ¸·Î ¾Æ¸£º¸¹ÙÀÌ·¯½º ÁúȯÀÇ ¹ß»ýÀÌ ±ÞÁõÇϰí ÀÖ´Â Ãß¼¼¿¡ ÈûÀÔ¾î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. °¨¿°º´ ´ëÀÀ ¹× °øÁߺ¸°Ç ´ëºñ¸¦ À§ÇÑ Á¤ºÎ ¹× ºñÁ¤ºÎ ±â±ÝÀÇ Áõ°¡´Â Áúº´ °¨½Ã ¹× Áø´Ü ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ¸¦ ÃËÁøÇϰí ÀÖÀ¸¸ç, PCR ¹× Â÷¼¼´ë ¿°±â¼¿ ºÐ¼®°ú °°Àº ºÐÀÚÁø´Ü ±â¼úÀÇ ¹ßÀüÀ¸·Î ¾Æ¸£º¸¹ÙÀÌ·¯½ºÀÇ ½Å¼ÓÇϰí Á¤È®ÇÑ °ËÃâÀÌ °¡´ÉÇØÁ® Á¶±â °³ÀÔ ¹× ¹ß»ý ¾ïÁ¦¸¦ ¿ëÀÌÇÏ°Ô Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹ßº´ Áö¿ª¿¡¼ÀÇ ÀÎÁöµµ Çâ»ó°ú ¼±º°°Ë»ç ÇÁ·Î±×·¥ ½ÃÇàÀÌ ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¾ïÁ¦¿äÀÎ
½ÃÀåÀº À¯¸ÁÇÑ Àü¸ÁÀ» °¡Áö°í ÀÖÁö¸¸, Àú¼Òµæ Áö¿ªÀÇ Á¦ÇÑµÈ Áø´Ü µµ±¸ Á¢±Ù¼º, Ç¥ÁØÈµÈ °Ë»ç ÇÁ·ÎÅäÄÝÀÇ ºÎÀç, ¼÷·ÃµÈ °Ë»ç Àη ºÎÁ· µîÀÇ ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ÀϺΠ±¹°¡¿¡¼´Â ºÐÀÚ °Ë»ç ºñ¿ëÀÌ ºñ½Î°í º¸Çè Àû¿ëÀÌ Á¦ÇÑÀûÀ̱⠶§¹®¿¡ ½ÃÀå ħÅõ°¡ ´õ¿í Á¦ÇÑÀûÀÔ´Ï´Ù. °èÀý°ú À¯Çà¿¡ µû¸¥ ¼ö¿ä º¯µ¿µµ Á¦Á¶¾÷üÀÇ »ý»ê °èȹ°ú ÀÚ¿ø ¹èºÐ¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ¶ÇÇÑ Ç÷ûÇÐÀû °Ë»ç¹ý, ƯÈ÷ Çöóºñ ¹ÙÀÌ·¯½º¿ÍÀÇ ±³Â÷ ¹ÝÀÀ¼ºÀº ¿ÀÁøÀ¸·Î À̾îÁú ¼ö ÀÖÀ¸¸ç, °Ë»çÀÇ ½Å·Ú¼º°ú ÀÓ»óÀû ÆÇ´Ü¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.
½ÃÀå ±âȸ
¾Æ¸£º¸¹ÙÀÌ·¯½º °Ë»ç ½ÃÀåÀº ½Å¼ÓÇÑ °á°ú¸¦ Á¦°øÇÏ°í ¹ßº´ ½Ã ÇöÀå¿¡¼ »ç¿ëÇÒ ¼ö ÀÖ´Â ÈÞ´ë¿ë ÇöÀå Áø´Ü ±â±âÀÇ Çõ½ÅÀ» ÅëÇØ Å« ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ¿ªÇÐ ¸ðµ¨¸µ¿¡¼ AI¿Í µ¥ÀÌÅÍ ºÐ¼®ÀÇ ÅëÇÕÀº Áúº´ ¿¹Ãø ¹× °Ë»ç ¹èÆ÷ Àü·«À» °ÈÇÕ´Ï´Ù. ¿¬±¸°³¹ßÀ» À§ÇÑ ¹Î°ü Çù·ÂÀÇ Áõ°¡¿Í ¿©·¯ ¾Æ¸£º¸¹ÙÀÌ·¯½º¸¦ µ¿½Ã¿¡ °ËÃâÇÒ ¼ö ÀÖ´Â ¸ÖƼÇ÷º½º ºÐ¼®ÀÇ µîÀåÀ¸·Î ¿öÅ©Ç÷ο츦 °£¼ÒÈÇϰí Áø´Ü ºñ¿ëÀ» Àý°¨ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿©Çà °ü·Ã °¨¿°À¸·Î ÀÎÇÑ ºñ À¯Çà Áö¿ª¿¡¼ÀÇ °Ë»ç È®´ë¿Í ¼¼°è Áúº´ °¨½Ã ³×Æ®¿öÅ©ÀÇ ±¸ÃàÀº ½ÃÀå È®´ëÀÇ ±æÀ» ´õ¿í ¿¾îÁÙ °ÍÀÔ´Ï´Ù.
ÀÌ º¸°í¼´Â ¼¼°è ¾Æ¸£º¸¹ÙÀÌ·¯½º °Ë»ç ½ÃÀåÀ» Á¶»çÇÏ¿© ¼ºÀå ÃËÁø¿äÀÎ, µ¿Çâ, ±âȸ, °úÁ¦ µî ½ÃÀå ¿ªÇп¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå ½ÃÀå °³¿ä
½ÃÀå ¹üÀ§¿Í Á¤ÀÇ
½ÃÀå ¿ªÇÐ
¼ºÀå ÃËÁø¿äÀÎ
¼ºÀå ¾ïÁ¦¿äÀÎ
±âȸ
°úÁ¦
ÁÖ¿ä µ¿Çâ
°Å½Ã°æÁ¦ ¿äÀÎ
¼¼°èÀÇ ºÎ¹® Àü¸Á
¼¼°èÀÇ GDP ¼ºÀå Àü¸Á
COVID-19ÀÇ ¿µÇ⠺м®
¿¹Ãø¿äÀÎ - °ü·Ã¼º°ú ¿µÇâ
Á¦3Àå ºÎ°¡°¡Ä¡ ÀλçÀÌÆ®
±ÔÁ¦ »óȲ
°Ë»ç À¯Çü ä¿ë ºÐ¼®
±â¼úÀÇ Áøº¸
Áúº´ ¿ªÇÐ
¹ë·ùüÀÎ ºÐ¼®
ÁÖ¿ä °Å·¡¿Í ÇÕº´
PESTLE ºÐ¼®
Porter's Five Forces ºÐ¼®
Á¦4Àå ¼¼°èÀÇ ¾Æ¸£º¸¹ÙÀÌ·¯½º °Ë»ç ½ÃÀå Àü¸Á
ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
½ÃÀå ±Ô¸ð¿Í Àü³âºñ ¼ºÀå
Àý´ëÀû ¼öÀÍ ±âȸ
½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø
½ÃÀå ±Ô¸ð ½ÇÀû ºÐ¼®(2019-2024³â)
ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø(2025-2032³â)
¼¼°èÀÇ ¾Æ¸£º¸¹ÙÀÌ·¯½º °Ë»ç ½ÃÀå Àü¸Á : °Ë»ç À¯Çü
¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
½ÃÀå ±Ô¸ð ½ÇÀû ºÐ¼® : °Ë»ç À¯Çüº°(2019-2024³â)
ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : °Ë»ç À¯Çüº°(2025-2032³â)
Ç÷ûÇÐÀû °Ë»ç
ºÐÀÚÁø´Ü °Ë»ç
±âŸ
½ÃÀå ¸Å·Â ºÐ¼® : °Ë»ç À¯Çü
¼¼°èÀÇ ¾Æ¸£º¸¹ÙÀÌ·¯½º °Ë»ç ½ÃÀå Àü¸Á : ¹ÙÀÌ·¯½º À¯Çü
¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
½ÃÀå ±Ô¸ð ½ÇÀû ºÐ¼® : ¹ÙÀÌ·¯½º À¯Çüº°(2019-2024³â)
ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ¹ÙÀÌ·¯½º À¯Çüº°(2025-2032³â)
µ±â¹ÙÀÌ·¯½º
ÁöÄ«¹ÙÀÌ·¯½º
Ä¡Äﱸ´Ï¾ß ¹ÙÀÌ·¯½º
Ȳ¿ ¹ÙÀÌ·¯½º
¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º
ÀϺ»³ú¿° ¹ÙÀÌ·¯½º
±âŸ
½ÃÀå ¸Å·Â ºÐ¼® : ¹ÙÀÌ·¯½º À¯Çü
¼¼°èÀÇ ¾Æ¸£º¸¹ÙÀÌ·¯½º °Ë»ç ½ÃÀå Àü¸Á : ÃÖÁ¾»ç¿ëÀÚ
¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
½ÃÀå ±Ô¸ð ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°(2019-2024³â)
ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°(2025-2032³â)
º´¿ø¡¤Áø·á¼Ò
Áø´Ü °Ë»ç½Ç
¿¬±¸ ¼¾ÅÍ
°øÁßÀ§»ý ±â°ü
Çмú±â°ü
½ÃÀå ¸Å·Â ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚ
Á¦5Àå ¼¼°èÀÇ ¾Æ¸£º¸¹ÙÀÌ·¯½º °Ë»ç ½ÃÀå Àü¸Á : Áö¿ª
ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
½ÃÀå ±Ô¸ð ½ÇÀû ºÐ¼® : Áö¿ªº°(2019-2024³â)
ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : Áö¿ªº°(2025-2032³â)
ºÏ¹Ì
À¯·´
µ¿¾Æ½Ã¾Æ
³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾Æ
¶óƾ¾Æ¸Þ¸®Ä«
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
½ÃÀå ¸Å·Â ºÐ¼® : Áö¿ª
Á¦6Àå ºÏ¹ÌÀÇ ¾Æ¸£º¸¹ÙÀÌ·¯½º °Ë»ç ½ÃÀå Àü¸Á
Á¦7Àå À¯·´ÀÇ ¾Æ¸£º¸¹ÙÀÌ·¯½º °Ë»ç ½ÃÀå Àü¸Á
Á¦8Àå µ¿¾Æ½Ã¾ÆÀÇ ¾Æ¸£º¸¹ÙÀÌ·¯½º °Ë»ç ½ÃÀå Àü¸Á
Á¦9Àå ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾ÆÀÇ ¾Æ¸£º¸¹ÙÀÌ·¯½º °Ë»ç ½ÃÀå Àü¸Á
Á¦10Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ¾Æ¸£º¸¹ÙÀÌ·¯½º °Ë»ç ½ÃÀå Àü¸Á
Á¦11Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¾Æ¸£º¸¹ÙÀÌ·¯½º °Ë»ç ½ÃÀå Àü¸Á
Á¦12Àå °æÀï ±¸µµ
½ÃÀå Á¡À¯À² ºÐ¼®(2025³â)
½ÃÀå ±¸Á¶
°æÀï °µµ ¸Ê : ½ÃÀ庰
°æÀï ´ë½Ãº¸µå
±â¾÷ °³¿ä(»ó¼¼ - °³¿ä, À繫, Àü·«, ÃÖ±Ù ¹ßÀü)
Abbott Laboratories
Roche Diagnostics
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
Siemens Healthineers AG
Danaher Corporation(includes Cepheid, Beckman Coulter)
QIAGEN N.V.
bioMerieux SA
Meridian Bioscience, Inc.
NovaTec Immundiagnostica GmbH
InBios International, Inc.
Artron Laboratories Inc.
SD Biosensor, Inc.
CTK Biotech, Inc.
Euroimmun AG(a PerkinElmer company)
±âŸ
Á¦13Àå ºÎ·Ï
ksm
Persistence Market Research has recently released a comprehensive report on the worldwide market for arbovirus testing. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global arbovirus testing market from 2025 to 2032.
Key Insights:
Arbovirus Testing Market Size (2025E): USD 1,094.4 Million
Projected Market Value (2032F): USD 1,521.1 Million
Global Market Growth Rate (CAGR 2025 to 2032): 4.8%
Arbovirus Testing Market - Report Scope:
Arbovirus testing plays a vital role in the diagnosis and surveillance of arthropod-borne viral infections such as dengue, Zika, chikungunya, yellow fever, and West Nile virus. These diseases are primarily transmitted by mosquitoes and ticks, posing significant public health challenges, particularly in tropical and subtropical regions. The arbovirus testing market comprises molecular diagnostics, serological tests, and point-of-care assays, used in hospitals, clinics, laboratories, and field surveillance programs. The increasing prevalence of arboviral outbreaks, coupled with rising global mobility and climate change effects on vector ecology, is driving demand for advanced diagnostic solutions.
Market Growth Drivers:
The global arbovirus testing market is propelled by the escalating incidence of arboviral diseases worldwide, driven by factors such as urbanization, global travel, and environmental changes that favor mosquito breeding. Rising government and non-governmental funding for infectious disease control and public health preparedness has spurred investments in disease surveillance and diagnostics infrastructure. Advancements in molecular diagnostic technologies, including PCR and next-generation sequencing, have enabled faster and more accurate detection of arboviruses, facilitating early intervention and outbreak containment. In addition, growing awareness and implementation of screening programs in endemic regions support market growth.
Market Restraints:
Despite the promising outlook, the market faces challenges including limited accessibility of diagnostic tools in low-income regions, lack of standardized testing protocols, and shortage of trained laboratory personnel. High costs associated with molecular tests and limited insurance coverage in some countries further restrict market penetration. Seasonal and outbreak-driven demand variability also affects production planning and resource allocation for manufacturers. Moreover, cross-reactivity in serological testing methods, particularly among flaviviruses, may lead to misdiagnosis, impacting test reliability and clinical decision-making.
Market Opportunities:
The arbovirus testing market presents substantial growth opportunities through innovations in portable, point-of-care diagnostic devices, which offer rapid results and are suitable for field use during outbreaks. Integration of artificial intelligence and data analytics in epidemiological modeling enhances disease forecasting and test deployment strategies. Increasing public-private partnerships for R&D and the emergence of multiplex assays capable of simultaneously detecting multiple arboviruses can streamline workflows and reduce diagnostic costs. Expansion of testing in non-endemic regions due to travel-related transmission and the establishment of global disease surveillance networks further open avenues for market expansion.
Key Questions Answered in the Report:
What are the primary factors driving the growth of the arbovirus testing market globally?
Which testing technologies and platforms are gaining traction in endemic and non-endemic regions?
How are innovations in molecular diagnostics influencing the arbovirus testing landscape?
Who are the key players in the arbovirus testing market, and what strategies are they employing to remain competitive?
What are the emerging trends and future prospects in the global arbovirus testing market?
Competitive Intelligence and Business Strategy:
Leading players in the global arbovirus testing market, including Abbott Laboratories, Thermo Fisher Scientific Inc., bioMerieux SA, and Bio-Rad Laboratories, Inc., are focusing on technology development, strategic collaborations, and geographical expansion to enhance their market presence. These companies are investing in advanced diagnostic platforms and launching rapid, multiplex, and high-throughput testing kits to address increasing demand for accurate and timely diagnostics. Partnerships with public health agencies and academic institutions support surveillance initiatives and product innovation. Continuous focus on regulatory approvals, training programs, and awareness campaigns is aiding in expanding market access, particularly in resource-limited settings.
Key Companies Profiled:
Abbott Laboratories
Roche Diagnostics
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
Siemens Healthineers AG
Danaher Corporation (includes Cepheid, Beckman Coulter)
QIAGEN N.V.
bioMerieux SA
Meridian Bioscience, Inc.
NovaTec Immundiagnostica GmbH
InBios International, Inc.
Artron Laboratories Inc.
SD Biosensor, Inc.
CTK Biotech, Inc.
Euroimmun AG (a PerkinElmer company)
Others
Market Segmentation
By Test Type
Serological Tests
Molecular Diagnostic Tests
Others
By Virus Type
Dengue Virus
Zika Virus
Chikungunya Virus
Yellow Fever Virus
West Nile Virus
Japanese Encephalitis Virus
Others
By End-user
Hospitals & Clinics
Diagnostic Laboratories
Research Centers
Public Health Agencies
Academic Institutions
By Region
North America
Europe
East Asia
South Asia and Oceania
Latin America
Middle East and Africa
Table of Contents
1. Executive Summary
1.1. Global Arbovirus Testing Market Snapshot, 2025-2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Regulatory Landscape
3.2. Test Type Adoption Analysis
3.3. Technological Advancements
3.4. Disease Epidemiology
3.5. Value Chain Analysis
3.6. Key Deals and Mergers
3.7. PESTLE Analysis
3.8. Porter's Five Force Analysis
4. Global Arbovirus Testing Market Outlook:
4.1. Key Highlights
4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Mn) Analysis and Forecast
4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
4.3. Global Arbovirus Testing Market Outlook: Test Type
4.3.1. Introduction / Key Findings
4.3.2. Historical Market Size (US$ Mn) Analysis, By Test Type, 2019-2024
4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
4.3.3.1. Serological Tests
4.3.3.2. Molecular Diagnostic Tests
4.3.3.3. Others
4.3.4. Market Attractiveness Analysis: Test Type
4.4. Global Arbovirus Testing Market Outlook: Virus Type
4.4.1. Introduction / Key Findings
4.4.2. Historical Market Size (US$ Mn) Analysis, By Virus Type, 2019-2024
4.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025-2032
4.4.3.1. Dengue Virus
4.4.3.2. Zika Virus
4.4.3.3. Chikungunya Virus
4.4.3.4. Yellow Fever Virus
4.4.3.5. West Nile Virus
4.4.3.6. Japanese Encephalitis Virus
4.4.3.7. Others
4.4.4. Market Attractiveness Analysis: Virus Type
4.5. Global Arbovirus Testing Market Outlook: End User
4.5.1. Introduction / Key Findings
4.5.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
4.5.3.1. Hospitals & Clinics
4.5.3.2. Diagnostic Laboratories
4.5.3.3. Research Centers
4.5.3.4. Public Health Agencies
4.5.3.5. Academic Institutions
4.5.4. Market Attractiveness Analysis: End User
5. Global Arbovirus Testing Market Outlook: Region
5.1. Key Highlights
5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
5.3.1. North America
5.3.2. Europe
5.3.3. East Asia
5.3.4. South Asia and Oceania
5.3.5. Latin America
5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region
6. North America Arbovirus Testing Market Outlook:
6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
6.2.1. By Country
6.2.2. By Test Type
6.2.3. By Virus Type
6.2.4. By End User
6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
6.3.1. U.S.
6.3.2. Canada
6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
6.4.1. Serological Tests
6.4.2. Molecular Diagnostic Tests
6.4.3. Others
6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025-2032
6.5.1. Dengue Virus
6.5.2. Zika Virus
6.5.3. Chikungunya Virus
6.5.4. Yellow Fever Virus
6.5.5. West Nile Virus
6.5.6. Japanese Encephalitis Virus
6.5.7. Others
6.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
6.6.1. Hospitals & Clinics
6.6.2. Diagnostic Laboratories
6.6.3. Research Centers
6.6.4. Public Health Agencies
6.6.5. Academic Institutions
6.7. Market Attractiveness Analysis
7. Europe Arbovirus Testing Market Outlook:
7.1. Key Highlights
7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
7.2.1. By Country
7.2.2. By Test Type
7.2.3. By Virus Type
7.2.4. By End User
7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
7.3.1. Germany
7.3.2. France
7.3.3. U.K.
7.3.4. Italy
7.3.5. Spain
7.3.6. Russia
7.3.7. Turkey
7.3.8. Rest of Europe
7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
7.4.1. Serological Tests
7.4.2. Molecular Diagnostic Tests
7.4.3. Others
7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025-2032
7.5.1. Dengue Virus
7.5.2. Zika Virus
7.5.3. Chikungunya Virus
7.5.4. Yellow Fever Virus
7.5.5. West Nile Virus
7.5.6. Japanese Encephalitis Virus
7.5.7. Others
7.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
7.6.1. Hospitals & Clinics
7.6.2. Diagnostic Laboratories
7.6.3. Research Centers
7.6.4. Public Health Agencies
7.6.5. Academic Institutions
7.7. Market Attractiveness Analysis
8. East Asia Arbovirus Testing Market Outlook:
8.1. Key Highlights
8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
8.2.1. By Country
8.2.2. By Test Type
8.2.3. By Virus Type
8.2.4. By End User
8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
8.3.1. China
8.3.2. Japan
8.3.3. South Korea
8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
8.4.1. Serological Tests
8.4.2. Molecular Diagnostic Tests
8.4.3. Others
8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025-2032
8.5.1. Dengue Virus
8.5.2. Zika Virus
8.5.3. Chikungunya Virus
8.5.4. Yellow Fever Virus
8.5.5. West Nile Virus
8.5.6. Japanese Encephalitis Virus
8.5.7. Others
8.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
8.6.1. Hospitals & Clinics
8.6.2. Diagnostic Laboratories
8.6.3. Research Centers
8.6.4. Public Health Agencies
8.6.5. Academic Institutions
8.7. Market Attractiveness Analysis
9. South Asia & Oceania Arbovirus Testing Market Outlook:
9.1. Key Highlights
9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
9.2.1. By Country
9.2.2. By Test Type
9.2.3. By Virus Type
9.2.4. By End User
9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
9.3.1. India
9.3.2. Southeast Asia
9.3.3. ANZ
9.3.4. Rest of South Asia & Oceania
9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
9.4.1. Serological Tests
9.4.2. Molecular Diagnostic Tests
9.4.3. Others
9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025-2032
9.5.1. Dengue Virus
9.5.2. Zika Virus
9.5.3. Chikungunya Virus
9.5.4. Yellow Fever Virus
9.5.5. West Nile Virus
9.5.6. Japanese Encephalitis Virus
9.5.7. Others
9.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
9.6.1. Hospitals & Clinics
9.6.2. Diagnostic Laboratories
9.6.3. Research Centers
9.6.4. Public Health Agencies
9.6.5. Academic Institutions
9.7. Market Attractiveness Analysis
10. Latin America Arbovirus Testing Market Outlook:
10.1. Key Highlights
10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
10.2.1. By Country
10.2.2. By Test Type
10.2.3. By Virus Type
10.2.4. By End User
10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
10.3.1. Brazil
10.3.2. Mexico
10.3.3. Rest of Latin America
10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
10.4.1. Serological Tests
10.4.2. Molecular Diagnostic Tests
10.4.3. Others
10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025-2032
10.5.1. Dengue Virus
10.5.2. Zika Virus
10.5.3. Chikungunya Virus
10.5.4. Yellow Fever Virus
10.5.5. West Nile Virus
10.5.6. Japanese Encephalitis Virus
10.5.7. Others
10.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
10.6.1. Hospitals & Clinics
10.6.2. Diagnostic Laboratories
10.6.3. Research Centers
10.6.4. Public Health Agencies
10.6.5. Academic Institutions
10.7. Market Attractiveness Analysis
11. Middle East & Africa Arbovirus Testing Market Outlook:
11.1. Key Highlights
11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
11.2.1. By Country
11.2.2. By Test Type
11.2.3. By Virus Type
11.2.4. By End User
11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
11.3.1. GCC Countries
11.3.2. Egypt
11.3.3. South Africa
11.3.4. Northern Africa
11.3.5. Rest of Middle East & Africa
11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
11.4.1. Serological Tests
11.4.2. Molecular Diagnostic Tests
11.4.3. Others
11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025-2032
11.5.1. Dengue Virus
11.5.2. Zika Virus
11.5.3. Chikungunya Virus
11.5.4. Yellow Fever Virus
11.5.5. West Nile Virus
11.5.6. Japanese Encephalitis Virus
11.5.7. Others
11.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
11.6.1. Hospitals & Clinics
11.6.2. Diagnostic Laboratories
11.6.3. Research Centers
11.6.4. Public Health Agencies
11.6.5. Academic Institutions
11.7. Market Attractiveness Analysis
12. Competition Landscape
12.1. Market Share Analysis, 2025
12.2. Market Structure
12.2.1. Competition Intensity Mapping By Market
12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
12.3.1. Abbott Laboratories
12.3.1.1. Overview
12.3.1.2. Segments and Test Types
12.3.1.3. Key Financials
12.3.1.4. Market Developments
12.3.1.5. Market Strategy
12.3.2. Roche Diagnostics
12.3.3. Thermo Fisher Scientific Inc.
12.3.4. Bio-Rad Laboratories, Inc.
12.3.5. Siemens Healthineers AG
12.3.6. Danaher Corporation (includes Cepheid, Beckman Coulter)
12.3.7. QIAGEN N.V.
12.3.8. bioMerieux SA
12.3.9. Meridian Bioscience, Inc.
12.3.10. NovaTec Immundiagnostica GmbH
12.3.11. InBios International, Inc.
12.3.12. Artron Laboratories Inc.
12.3.13. SD Biosensor, Inc.
12.3.14. CTK Biotech, Inc.
12.3.15. Euroimmun AG (a PerkinElmer company)
12.3.16. Others
13. Appendix
13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations